Cholesterol and affective morbidity

Psychiatry Research

Volumn 175, Issue 1-2, 2010, Pages 78-81

  Fiedorowicz, Jess G ^a   Palagummi, Narasimha M ^b   Behrendtsen, Ole ^a   Coryell, William H ^a  

^a UNIVERSITY OF IOWA   (United States)

^b Marshalltown Medical Clinic   (United States)

Author keywords

Bipolar disorder; Cholesterol; Depression; Major depression; Mania

Indexed keywords

CHOLESTEROL; MOOD STABILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CLINICAL EVALUATION; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; NEUROBIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPTOMATOLOGY;

ADULT; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MOOD DISORDERS; MORBIDITY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 72049092024     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.01.001     Document Type: Article

References (57)

1. Abulrob A., Tauskela J.S., Mealing G., Brunette E., Faid K., and Stanimirovic D. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-d-aspartate receptor redistribution. Journal of Neurochemistry 92 (2005) 1477-1486
2. Arnett D.K., McGovern P.G., Jacobs Jr. D.R., Shahar E., Duval S., Blackburn H., and Luepker R.V. Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey. American Journal of Epidemiology 156 (2002) 929-935
3. Atmaca M., Kuloglu M., Tezcan E., Ustundag B., and Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology 46 (2002) 176-179
4. Beasley C.L., Honer W.G., Bergmann K., Falkai P., Lutjohann D., and Bayer T.A. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disorders 7 (2005) 449-455
5. Berns M.A., de Vries J.H., and Katan M.B. Determinants of the increase of serum cholesterol with age: a longitudinal study. International Journal of Epidemiology 17 (1988) 789-796
6. Bocchetta A., Chillotti C., Carboni G., Oi A., Ponti M., and Del Zompo M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatrica Scandinavica 104 (2001) 37-41
7. Butchbach M.E., Tian G., Guo H., and Lin C.L. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. Journal of Biological Chemistry 279 (2004) 34388-34396
8. Cassidy F., and Carroll B.J. Hypocholesterolemia during mixed manic episodes. European Archives of Psychiatry and Clinical Neuroscience 252 (2002) 110-114
9. Chung K.H., Tsai S.Y., and Lee H.C. Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. Psychiatry and Clinical Neurosciences 61 (2007) 428-433
10. Coryell W., and Schlesser M. Combined biological tests for suicide prediction. Psychiatry Research 150 (2007) 187-191
11. Coryell W., Solomon D., Turvey C., Keller M., Leon A.C., Endicott J., Schettler P., Judd L., and Mueller T. The long-term course of rapid-cycling bipolar disorder. Archives of General Psychiatry 60 (2003) 914-920
12. Deisenhammer E.A., Kramer-Reinstadler K., Liensberger D., Kemmler G., Hinterhuber H., and Fleischhacker W.W. No evidence for an association between serum cholesterol and the course of depression and suicidality. Psychiatry Research 121 (2004) 253-261
13. Diaz-Sastre C., Baca-Garcia E., Perez-Rodriguez M.M., Garcia-Resa E., Ceverino A., Saiz-Ruiz J., Oquendo M.A., and de Leon J. Low plasma cholesterol levels in suicidal males: a gender- and body mass index-matched case-control study of suicide attempters and nonattempters. Progress in Neuropsychopharmacology and Biological Psychiatry 31 (2007) 901-905
14. Ellison L.F., and Morrison H.I. Low serum cholesterol concentration and risk of suicide. Epidemiology 12 (2001) 168-172
15. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 35 (1978) 837-844
16. Endicott J., and Spitzer R.L. Use of the research diagnostic criteria and the schedule for affective disorders and schizophrenia to study affective disorders. American Journal of Psychiatry 136 (1979) 52-56
17. Engstrom G., Alsen M., Regnell G., and Traskman-Bendz L. Serum lipids in suicide attempters. Suicide and Life-Threatening Behavior 25 (1995) 393-400
18. Fagiolini A., Frank E., Scott J.A., Turkin S., and Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disorders 7 (2005) 424-430
19. Fiedorowicz J.G., and Coryell W.H. Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatry Research 152 (2007) 11-20
20. Fiedorowicz J.G., Palagummi N.M., Forman-Hoffman V.L., Miller del D., and Haynes W.G. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Annals of Clinical Psychiatry 20 (2008) 131-137
21. Fiedorowicz J.G., Leon A.C., Keller M.B., Solomon D.A., Rice J.P., and Coryell W.H. Do risk factors for suicidal behavior differ by affective disorder polarity?. Psychological Medicine 39 5 (2009) 763-771
22. Frank C., Giammarioli A.M., Pepponi R., Fiorentini C., and Rufini S. Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS Letters 566 (2004) 25-29
23. Gabriel A. Changes in plasma cholesterol in mood disorder patients: does treatment make a difference?. Journal of Affective Disorders 99 (2007) 273-278
24. Ghaemi S.N., Shields G.S., Hegarty J.D., and Goodwin F.K. Cholesterol levels in mood disorders: high or low?. Bipolar Disorders 2 (2000) 60-64
25. Gil C., Cubi R., Blasi J., and Aguilera J. Synaptic proteins associate with a sub-set of lipid rafts when isolated from nerve endings at physiological temperature. Biochemical and Biophysical Research Communications 348 (2006) 1334-1342
26. Glueck C.J., Tieger M., Kunkel R., Hamer T., Tracy T., and Speirs J. Hypocholesterolemia and affective disorders. American Journal of Medical Science 308 (1994) 218-225
27. Golier J.A., Marzuk P.M., Leon A.C., Weiner C., and Tardiff K. Low serum cholesterol level and attempted suicide. American Journal of Psychiatry 152 (1995) 419-423
28. Golomb B.A., Tenkanen L., Alikoski T., Niskanen T., Manninen V., Huttunen M., and Mednick S.A. Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees. Journal of Clinical Epidemiology 55 (2002) 767-773
29. Huang P., Xu W., Yoon S.I., Chen C., Chong P.L., and Liu-Chen L.Y. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochemical Pharmacology 73 (2007) 534-549
30. Jow G.M., Yang T.T., and Chen C.L. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. Journal of Affective Disorders 90 (2006) 21-27
31. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., Paulus M.P., Kunovac J.L., Leon A.C., Mueller T.I., Rice J.A., and Keller M.B. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders 50 (1998) 97-108
32. Judd L.L., Schettler P.J., Akiskal H.S., Maser J., Coryell W., Solomon D., Endicott J., and Keller M. Long-term symptomatic status of bipolar I vs. bipolar II disorders. International Journal of Neuropsychopharmacology 6 (2003) 127-137
33. Keller M.B., Lavori P.W., Friedman B., Nielsen E., Endicott J., McDonald-Scott P., and Andreasen N.C. The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44 (1987) 540-548
34. Kopf D., Westphal S., Luley C.W., Ritter S., Gilles M., Weber-Hamann B., Lederbogen F., Lehnert H., Henn F.A., Heuser I., and Deuschle M. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. Journal of Clinical Psychopharmacology 24 (2004) 527-531
35. Lindberg G., Rastam L., Gullberg B., and Eklund G.A. Low serum cholesterol concentration and short term mortality from injuries in men and women. British Medical Journal 305 (1992) 277-279
36. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., and Meltzer H.Y. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research 85 (1999) 275-291
37. Morgan R.E., Palinkas L.A., Barrett-Connor E.L., and Wingard D.L. Plasma cholesterol and depressive symptoms in older men. The Lancet 341 (1993) 75-79
38. Muldoon M.F., Manuck S.B., and Matthews K.A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal 301 (1990) 309-314
39. Nakao M., and Yano E. Relationship between major depression and high serum cholesterol in Japanese men. The Tohoku Journal of Experimental Medicine 204 (2004) 273-287
40. Neaton J.D., Blackburn H., Jacobs D., Kuller L., Lee D.J., Sherwin R., Shih J., Stamler J., and Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Archives of Internal Medicine 152 (1992) 1490-1500
41. Olusi S.O., and Fido A.A. Serum lipid concentrations in patients with major depressive disorder. Biological Psychiatry 40 (1996) 1128-1131
42. Oxenkrug G.F., Branconnier R.J., Harto-Truax N., and Cole J.O. Is serum cholesterol a biological marker for major depressive disorder?. American Journal of Psychiatry 140 (1983) 920-921
43. Pae C.U., Kim J.J., Lee S.J., Lee C., Paik I.H., and Lee C.U. Aberration of cholesterol level in first-onset bipolar I patients. Journal of Affective Disorders 83 (2004) 79-82
44. Papakostas G.I., Petersen T., Mischoulon D., Hughes M.E., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., and Fava M. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Research 118 (2003) 137-145
45. Papakostas G.I., Petersen T., Sonawalla S.B., Merens W., Iosifescu D.V., Alpert J.E., Fava M., and Nierenberg A.A. Serum cholesterol in treatment-resistant depression. Neuropsychobiology 47 (2003) 146-151
46. Papakostas G.I., Iosifescu D.V., Petersen T., Hamill S.K., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., and Fava M. Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder. Journal of Clinical Psychopharmacology 24 (2004) 467-469
47. Partonen T., Haukka J., Virtamo J., Taylor P.R., and Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. British Journal of Psychiatry 175 (1999) 259-262
48. Sagud M., Mihaljevic-Peles A., Pivac N., Jakovljevic M., and Muck-Seler D. Platelet serotonin and serum lipids in psychotic mania. Journal of Affective Disorders 97 (2007) 247-251
49. Scanlon S.M., Williams D.C., and Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40 (2001) 10507-10513
50. Singh P., Paila Y.D., and Chattopadhyay A. Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin(1A) receptor: implications in SLOS. Biochemical and Biophysics Research Communications 358 (2007) 495-499
51. Sjogren B., Hamblin M.W., and Svenningsson P. Cholesterol depletion reduces serotonin binding and signaling via human 5-HT(7(a)) receptors. European Journal of Pharmacology 552 (2006) 1-10
52. Solomon D.A., Leon A.C., Endicott J., Coryell W.H., Mueller T.I., Posternak M.A., and Keller M.B. Unipolar mania over the course of a 20-year follow-up study. American Journal of Psychiatry 160 (2003) 2049-2051
53. Sooksawate T., and Simmonds M.A. Effects of membrane cholesterol on the sensitivity of the GABA(A) receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology 40 (2001) 178-184
54. Sooksawate T., and Simmonds M.A. Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators. British Journal of Pharmacology 134 (2001) 1303-1311
55. Spitzer R.L., Endicott J., and Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 35 (1978) 773-782
56. Swartz C.M. Albumin decrement in depression and cholesterol decrement in mania. Journal of Affective Disorders 19 (1990) 173-176
57. Volek J.S., Gomez A.L., Love D.M., Weyers A.M., Hesslink Jr. R., Wise J.A., and Kraemer W.J. Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition. European Journal of Clinical Nutrition 56 (2002) 585-592